Dr. Xiao-Fang Yu is currently a tenured Professor at the Department of Molecular Microbiology and Immunology of Johns Hopkin University. He received Ph.D from the Harvard School of Public Health in 1990. Since then, Dr. Yu started his career as Research Associate at the Department of Cancer Biology in Harvard School of Public Health and Harvard AIDS Institute, followed by Assistant Professor at Department of Molecular Microbiology and Immunology of Johns Hopkin University since 1993, and finally as Professor in 2004.
Tremendous academic achievements are received by Dr. Xiao-Fang Yu, who has been focusing on HIV and other viral studies in Epidemiology, phylogenetic analysis, virus-host interaction, viral protein functions, host antiviral mechanisms, and vaccine development. To date, Dr. Yu has received over 20 academic grants from National Institute of Health, and published 145 papers, including ones accepted by top-level journals like Nature, Science, Lancet, etc. He is also the patent holder for the only HIV-1 vaccine entering phase-II trial in China.
Meanwhile, Dr. Yu also participates in many other academic activities. For example, he is the Editor for online open-access journal PLoS One, and he reviews research papers for various journals such as Nature Biotechnology, Nature Structure and Molecular Biology, Cell Host & Microbe, and Journal of Virology, and grant applications for NIAID, NIH, and The Wellcome Trust. In addition, Dr. Yu was invited as Section Chair or Keynote Speaker in many conference meetings including Retroviruses meeting at Cold Spring Harbor Laboratory and Conference on retroviruses and Opportunistic Infection.
In 2012, Dr. Yu was invited to join MR Healthcare. Thanks to his strong leadership and his great know-how, MR’s R&D team has been making great effort for the fast development of this company. He enhances MR to focus on the trend, technology development, and market needs. That is the key factor of MR’s success. Dr. Yu ensures MR to launch at least 3 new products into the markets each year.
